Dr Christiane Hamacher
-
Biocon posts Q2FY21 revenue at Rs 1,760 cr
Net profit has been posted at Rs 174 crore Biocon has announced its consolidated financial results for the fiscal second…
Read More » -
Biocon’s Q4 Profit Slumps 42% as Covid-19 Pandemic Hampers Biosimilars Segment
Bengaluru: Biocon Ltd.’s fourth-quarter net profit fell 42% from the previous quarter as the covid-19 pandemic led to a decline…
Read More » -
Biocon, Mylan Win Patent Litigation against Sanofi for Insulin Glargine Device
Bengaluru: Biocon Ltd. won a U.S.court ruling that invalidated a Sanofi patent on the Insulin Glargine device, removing a key…
Read More »